Hemolytic uremic syndrome associated with Denys-Drash syndrome

被引:15
|
作者
Sherbotie, JR
van Heyningen, V
Axton, R
Williamson, K
Finn, LS
Kaplan, BS [1 ]
机构
[1] Childrens Hosp Philadelphia, Dept Pediat, Div Nephrol, Philadelphia, PA 19104 USA
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland
[4] Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA 19104 USA
基金
英国医学研究理事会;
关键词
hemolytic uremic syndrome; Denys-Drash syndrome; diffuse mesangial sclerosis; Wilms' tumor; pseudohermaphroditism; WT1; mutation;
D O I
10.1007/s004670000389
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The Denys-Drash syndrome is defined by the occurrence of combinations of pseudohermaphroditism, nephrotic syndrome with diffuse mesangial sclerosis, Wilms' tumor, and constitutional mutations in the WT1 suppressor gene. Most patients develop end-stage renal failure. Atypical hemolytic uremic syndrome (HUS) is defined by onset of acute hemolytic anemia with fragmented erythrocytes, thrombocytopenia, and renal failure in the absence of a gastrointestinal prodromal illness of bloody diarrhea. The purpose of this report is to describe the occurrence of features of atypical HUS and Denys-Drash syndrome in two African-American boys aged 13 and 16 months. Each had nephrotic syndrome, diffuse mesangial sclerosis, and WT1 point mutations. Both had grade III hypospadias and undescended testes. They had normal serum creatinine concentrations and hematology a month before presenting with HUS, Stool cultures for Escherichia coli O157:H7 were negative. Each patient has been transplanted with cadaver kidneys without recurrence of HUS.
引用
收藏
页码:1092 / 1097
页数:6
相关论文
共 50 条
  • [21] In utero nephropathy, Denys-Drash syndrome and Potter phenotype
    Maalouf, EF
    Ferguson, J
    van Heyningen, V
    Modi, N
    PEDIATRIC NEPHROLOGY, 1998, 12 (06) : 449 - 451
  • [22] Gonadal Effects of a Mouse Denys-Drash Syndrome Mutation
    C.E. Patek
    P.T.K. Saunders
    C.G. Miles
    R.L. Berry
    N.D. Hastie
    R.M. Sharpe
    M.L. Hooper
    Transgenic Research, 2005, 14 : 691 - 702
  • [23] The dysregulated glomerular cell growth in Denys-Drash syndrome
    Yang, AH
    Chen, JY
    Chen, BF
    VIRCHOWS ARCHIV, 2004, 445 (03) : 305 - 314
  • [24] A RARE CASE OF DENYS-DRASH SYNDROME PRESENTING AS PNEUMOPERITONEUM
    Chuang, Gwo-Tsann
    PEDIATRIC NEPHROLOGY, 2021, 36 (09) : 2946 - 2946
  • [25] Denys-Drash Syndrome links developmental biology to oncogenesis
    Rowe, Jared H.
    JOURNAL OF PEDIATRICS, 2020, 219 : 145 - 145
  • [26] In utero nephropathy, Denys-Drash syndrome and Potter phenotype
    E. F. Maalouf
    J. Ferguson
    V. van Heyningen
    N. Modi
    Pediatric Nephrology, 1998, 12 : 449 - 451
  • [27] Gonadal effects of a mouse denys-drash syndrome mutation
    Patek, CE
    Saunders, PTK
    Miles, CG
    Berry, RL
    Hastie, ND
    Sharpe, RM
    Hooper, ML
    TRANSGENIC RESEARCH, 2005, 14 (05) : 691 - 702
  • [28] Clinical course of congenital nephrotic syndrome and Denys-Drash syndrome in Japan
    Motoyama, O
    Arai, K
    Kawamura, T
    Aikawa, A
    Ohara, T
    Iitaka, K
    Hasegawa, A
    PEDIATRICS INTERNATIONAL, 2005, 47 (06) : 607 - 611
  • [29] A familial WT1 mutation associated with incomplete Denys-Drash syndrome
    Zhu, Chunhua
    Zhao, Fei
    Zhang, Weizhen
    Wu, Hongmei
    Chen, Ying
    Ding, Guixia
    Zhang, Aihua
    Huang, Songming
    EUROPEAN JOURNAL OF PEDIATRICS, 2013, 172 (10) : 1357 - 1362
  • [30] INHERITED WT1 MUTATION IN DENYS-DRASH SYNDROME
    COPPES, MJ
    LIEFERS, GJ
    HIGUCHI, M
    ZINN, AB
    BALFE, JW
    WILLIAMS, BRG
    CANCER RESEARCH, 1992, 52 (21) : 6125 - 6128